• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病与糖摄入量:一种尚未明确的渴望的原因和后果。

Parkinson's Disease and Sugar Intake-Reasons for and Consequences of a Still Unclear Craving.

机构信息

Department of Neurology, Christian-Albrechts-University, Arnold-Heller-Str. 3, 24105 Kiel, Germany.

Institute for Human Nutrition and Food Science, Christian-Albrechts-University, 24105 Kiel, Germany.

出版信息

Nutrients. 2022 Aug 8;14(15):3240. doi: 10.3390/nu14153240.

DOI:10.3390/nu14153240
PMID:35956417
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9370710/
Abstract

Lately, studies have shown that patients with Parkinson's disease (PD) report a strong craving for sweets and consume significantly more fast-acting carbohydrates than healthy controls. Consuming food with a high-sugar content is assumed to lead to an increase in insulin concentration, which could positively influence dopamine concentration in the brain and unconsciously be used by patients as kind of "self-medication" to compensate for a lack of dopamine in PD. On the other hand, high-sugar intake could also lead to insulin resistance and diabetes, which is discussed as a causative factor for progressive neurodegeneration in PD. In this critical appraisal, we discuss the role of sugar intake and insulin on dopamine metabolism in patients with PD and how this could influence the potential neurodegeneration mediated by insulin resistance.

摘要

最近的研究表明,帕金森病(PD)患者强烈渴望甜食,并且比健康对照组消耗更多的快速作用碳水化合物。人们认为,食用高糖含量的食物会导致胰岛素浓度升高,这可能会对大脑中的多巴胺浓度产生积极影响,并且患者会不自觉地将其用作“自我治疗”来弥补 PD 中多巴胺的缺乏。另一方面,高糖摄入也可能导致胰岛素抵抗和糖尿病,这被认为是 PD 中进行性神经退行性变的一个致病因素。在这篇批判性评价中,我们讨论了糖摄入和胰岛素对 PD 患者多巴胺代谢的作用,以及这如何影响胰岛素抵抗介导的潜在神经退行性变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa5d/9370710/acaa0af1c2a4/nutrients-14-03240-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa5d/9370710/acaa0af1c2a4/nutrients-14-03240-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa5d/9370710/acaa0af1c2a4/nutrients-14-03240-g001.jpg

相似文献

1
Parkinson's Disease and Sugar Intake-Reasons for and Consequences of a Still Unclear Craving.帕金森病与糖摄入量:一种尚未明确的渴望的原因和后果。
Nutrients. 2022 Aug 8;14(15):3240. doi: 10.3390/nu14153240.
2
Increased Intake of Fast-Acting Carbohydrates in Patients with Parkinson's Disease.帕金森病患者摄入更多快速作用碳水化合物。
Neurodegener Dis. 2021;21(3-4):103-108. doi: 10.1159/000520594. Epub 2021 Nov 9.
3
Insulin resistance and Parkinson's disease: A new target for disease modification?胰岛素抵抗与帕金森病:疾病修饰的新靶点?
Prog Neurobiol. 2016 Oct-Nov;145-146:98-120. doi: 10.1016/j.pneurobio.2016.10.001. Epub 2016 Oct 3.
4
Network degeneration in Parkinson's disease: multimodal imaging of nigro-striato-cortical dysfunction.帕金森病中的网络退化:黑质纹状体皮质功能障碍的多模态成像。
Brain. 2020 Mar 1;143(3):944-959. doi: 10.1093/brain/awaa019.
5
Cognitive states influence dopamine-driven aberrant learning in Parkinson's disease.认知状态影响帕金森病中多巴胺驱动的异常学习。
Cortex. 2017 May;90:115-124. doi: 10.1016/j.cortex.2017.02.021. Epub 2017 Mar 20.
6
Nitric oxide and dopamine metabolism converge via mitochondrial dysfunction in the mechanisms of neurodegeneration in Parkinson's disease.一氧化氮和多巴胺代谢通过线粒体功能障碍在帕金森病神经退行性变的机制中汇聚。
Arch Biochem Biophys. 2021 Jun 15;704:108877. doi: 10.1016/j.abb.2021.108877. Epub 2021 Apr 14.
7
Common pathophysiology affecting diabetic retinopathy and Parkinson's disease.影响糖尿病视网膜病变和帕金森病的常见病理生理学。
Med Hypotheses. 2015 Oct;85(4):397-8. doi: 10.1016/j.mehy.2015.06.016. Epub 2015 Jun 26.
8
Parkinson's Disease, Diabetes and Cognitive Impairment.帕金森病、糖尿病与认知障碍。
Recent Pat Endocr Metab Immune Drug Discov. 2016;10(1):11-21. doi: 10.2174/1872214810999160628105549.
9
Elevated nuclear phosphatase and tensin homolog (PTEN) and altered insulin signaling in substantia nigral region of patients with Parkinson's disease.帕金森病患者黑质区域中核磷酸酶和张力蛋白同源物(PTEN)水平升高及胰岛素信号改变。
Neurosci Lett. 2018 Feb 14;666:139-143. doi: 10.1016/j.neulet.2017.12.049. Epub 2017 Dec 26.
10
Type 2 Diabetes and Parkinson's Disease: A Focused Review of Current Concepts.2型糖尿病与帕金森病:当前概念的重点综述
Mov Disord. 2023 Feb;38(2):162-177. doi: 10.1002/mds.29298. Epub 2022 Dec 26.

引用本文的文献

1
Association between intake of various sugar subtypes and common mental disorders: A large prospective study.不同糖亚型的摄入量与常见精神障碍之间的关联:一项大型前瞻性研究。
J Nutr Health Aging. 2025 Aug 13;29(10):100647. doi: 10.1016/j.jnha.2025.100647.
2
Modifiable risk factors associated with the risk of developing Parkinson's disease: a critical review.与帕金森病发病风险相关的可改变风险因素:一项批判性综述
Arq Neuropsiquiatr. 2025 Mar;83(3):1-10. doi: 10.1055/s-0045-1805075. Epub 2025 Mar 19.
3
Serotype and distribution of adhesion genes in Streptococcus mutans isolated from people with Parkinson's disease.

本文引用的文献

1
Glucagon-Like Peptide-1 Receptor Agonist Ameliorates 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) Neurotoxicity Through Enhancing Mitophagy Flux and Reducing α-Synuclein and Oxidative Stress.胰高血糖素样肽-1受体激动剂通过增强线粒体自噬通量、减少α-突触核蛋白和氧化应激来改善1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)神经毒性。
Front Mol Neurosci. 2021 Jul 7;14:697440. doi: 10.3389/fnmol.2021.697440. eCollection 2021.
2
Metformin attenuates rotenone-induced oxidative stress and mitochondrial damage via the AKT/Nrf2 pathway.二甲双胍通过 AKT/Nrf2 通路减轻鱼藤酮诱导的氧化应激和线粒体损伤。
Neurochem Int. 2021 Sep;148:105120. doi: 10.1016/j.neuint.2021.105120. Epub 2021 Jun 29.
3
从帕金森病患者分离出的变形链球菌中粘附基因的血清型及分布
Odontology. 2025 Mar 6. doi: 10.1007/s10266-025-01078-5.
4
Dietary and Lifestyle Factors of Brain Iron Accumulation and Parkinson's Disease Risk.脑铁蓄积与帕金森病风险的饮食和生活方式因素
medRxiv. 2024 Mar 15:2024.03.13.24304253. doi: 10.1101/2024.03.13.24304253.
5
Unravelling cell type-specific responses to Parkinson's Disease at single cell resolution.解析帕金森病在单细胞分辨率下的细胞类型特异性反应。
Mol Neurodegener. 2024 Jan 20;19(1):7. doi: 10.1186/s13024-023-00699-0.
6
Chronic high-sugar diet in adulthood protects Caenorhabditis elegans from 6-OHDA-induced dopaminergic neurodegeneration.成年期慢性高糖饮食可保护秀丽隐杆线虫免受 6-OHDA 诱导的多巴胺能神经退行性变。
BMC Biol. 2023 Nov 10;21(1):252. doi: 10.1186/s12915-023-01733-9.
7
[The exposome in the context of preventive measures for Alzheimer's and Parkinson's diseases].[阿尔茨海默病和帕金森病预防措施背景下的暴露组]
Nervenarzt. 2023 Oct;94(10):892-903. doi: 10.1007/s00115-023-01538-9. Epub 2023 Aug 28.
8
Changes in Liver Lipidomic Profile in G2019S- Mouse Model of Parkinson's Disease.G2019S 突变型帕金森病小鼠模型中肝脏脂质组学谱的变化。
Cells. 2023 Mar 4;12(5):806. doi: 10.3390/cells12050806.
The GLP-1/GIP dual-receptor agonist DA5-CH inhibits the NF-κB inflammatory pathway in the MPTP mouse model of Parkinson's disease more effectively than the GLP-1 single-receptor agonist NLY01.
GLP-1/GIP 双重受体激动剂 DA5-CH 在 MPTP 帕金森病小鼠模型中比 GLP-1 单受体激动剂 NLY01 更有效地抑制 NF-κB 炎症通路。
Brain Behav. 2021 Aug;11(8):e2231. doi: 10.1002/brb3.2231. Epub 2021 Jun 14.
4
Effect of lobeglitazone on motor function in rat model of Parkinson's disease with diabetes co-morbidity.罗格列酮对伴发糖尿病的帕金森病大鼠模型运动功能的影响。
Brain Res Bull. 2021 Aug;173:184-192. doi: 10.1016/j.brainresbull.2021.05.011. Epub 2021 May 26.
5
Increased Added Sugar Consumption Is Common in Parkinson's Disease.帕金森病患者中添加糖的摄入量增加很常见。
Front Nutr. 2021 May 7;8:628845. doi: 10.3389/fnut.2021.628845. eCollection 2021.
6
Beneficial effects of dipeptidyl peptidase-4 inhibitors in diabetic Parkinson's disease.二肽基肽酶-4 抑制剂在糖尿病性帕金森病中的有益作用。
Brain. 2021 May 7;144(4):1127-1137. doi: 10.1093/brain/awab015.
7
Sustained Release GLP-1 Agonist PT320 Delays Disease Progression in a Mouse Model of Parkinson's Disease.长效胰高血糖素样肽-1激动剂PT320延缓帕金森病小鼠模型的疾病进展。
ACS Pharmacol Transl Sci. 2021 Mar 16;4(2):858-869. doi: 10.1021/acsptsci.1c00013. eCollection 2021 Apr 9.
8
MicroRNAs, Parkinson's Disease, and Diabetes Mellitus.微小 RNA、帕金森病和糖尿病。
Int J Mol Sci. 2021 Mar 14;22(6):2953. doi: 10.3390/ijms22062953.
9
Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression.2型糖尿病作为帕金森病风险和进展的一个决定因素。
Mov Disord. 2021 Jun;36(6):1420-1429. doi: 10.1002/mds.28551. Epub 2021 Mar 8.
10
Targeting ROS-Dependent AKT/GSK-3β/NF-κB and DJ-1/Nrf2 Pathways by Dapagliflozin Attenuates Neuronal Injury and Motor Dysfunction in Rotenone-Induced Parkinson's Disease Rat Model.达格列净通过靶向 ROS 依赖的 AKT/GSK-3β/NF-κB 和 DJ-1/Nrf2 通路减轻鱼藤酮诱导的帕金森病大鼠模型中的神经元损伤和运动功能障碍。
ACS Chem Neurosci. 2021 Feb 17;12(4):689-703. doi: 10.1021/acschemneuro.0c00722. Epub 2021 Feb 5.